Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/13528
Type
ArticleCopyright
Open access
Collections
- INI - Artigos de Periódicos [3646]
- IOC - Artigos de Periódicos [12976]
Metadata
Show full item record37
CITATIONS
37
Total citations
3
Recent citations
4.48
Field Citation Ratio
1.13
Relative Citation Ratio
HIV CONTROLLERS WITH DIFFERENT VIRAL LOAD CUT-OFF LEVELS HAVE DISTINCT VIROLOGIC AND IMMUNOLOGIC PROFILES
Elite controllers
Viral load blips
Ongoing replication
Immune activation
Immune response
Microbial translocation
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
University of Miami. Miller School of Medicine. Department of Medicine. Miami, FL, USA.
University of Miami. Miller School of Medicine. Department of Medicine. Miami, FL, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
University of Miami. Miller School of Medicine. Department of Medicine. Miami, FL, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
University of Miami. Miller School of Medicine. Department of Medicine. Miami, FL, USA.
University of Miami. Miller School of Medicine. Department of Medicine. Miami, FL, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
University of Miami. Miller School of Medicine. Department of Medicine. Miami, FL, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Abstract
Background—The mechanisms behind natural control of HIV replication are still unclear, and
several studies pointed that elite controllers are a heterogeneous group.
Methods—We performed analyses of virologic, genetic and immunologic parameters of HIV-1
controllers groups: 1) Elite Controllers (EC; VL <80 copies/mL); 2) Ebbing Elite Controllers
(EEC; transient viremia/blips); and Viremic Controllers (VC; detectable viremia <5,000 copies/
mL). Untreated non-controllers (NC), patients under suppressive HAART and HIV-1 negative
individuals were analyzed as controls.
Results—Total and integrated HIV-1 DNA for EC were significantly lower than for NC and
HAART groups. 2-LTR circles were detected in EEC (3/5) and VC (6/7) but not in EC. While EC
and EEC maintain normal T cell counts over time, some VC displayed negative CD4+ T cells
slopes. VC and EEC showed a higher percentage of activated CD8+ T cells and microbial
translocation than HIV-1 negative controls. EC displayed a weaker Gag/Nef IFN-γ T cell response
and a significantly lower proportion of anti-HIV IgG antibodies than EEC, VC and NC groups.
Conclusion—Transient/persistent low level viremia in HIV controllers may have an impact on
immunologic and virologic profiles. Classify HIV controllers patients taking into account their virologic profile may decrease the heterogeneity of HIV controllers cohorts, which may help to
clarify the mechanisms associated to the elite control of HIV.
Keywords
HIV-1Elite controllers
Viral load blips
Ongoing replication
Immune activation
Immune response
Microbial translocation
Share